Mb-07803
データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
882757-24-6CCOC(=O)C(C)(C)NP(=O)(NC(C)(C)C(=O)OCC)c1ccc(-c2nc(N)sc2C(=O)C(C)(C)C)o1CTKZZUXRWBCFEI-UHFFFAOYSA-NMB07803 is a second generation gluconeogenesis inhibitor for the treatment of type 2 diabetes. It is designed to block the metabolic pathway in the liver that is responsible for producing glucose.
MB07803 is a selective inhibitor of fructose-1, 6-bisphosphatase (FBPase), a regulatory enzyme in the pathway responsible for the production of glucose in the liver, known as the gluconeogenesis pathway. By specifically inhibiting this pathway, liver glucose production should be reduced and blood sugar levels decreased in patients with diabetes, independent of insulin levels and body weight.
現在のフィルター条件では反応記録がありません。
読み込み中…
882757-24-6DTXSID90236932CHEMBL4297400